🚀📉 Cathie Wood rotates again: gene editing and autonomy in, $TSLA exposure trimmed by ~$30M

Cathie Wood isn’t de-risking.

She’s re-aligning conviction.

Over recent sessions, ARK Invest increased exposure to gene-editing, autonomous mobility, and next-gen energy, while continuing to trim legacy high-weight positions — most notably $TSLA.

This isn’t a macro call. It’s a portfolio geometry shift.

First, gene editing is quietly moving back to the center.

ARK added meaningfully to $CRSP, increasing exposure by roughly $8.8M.

Additional accumulation showed up in $PACB across both $ARKK and $ARKG, alongside smaller adds in $BEAM and $TWST.

This cluster matters.

Gene editing, sequencing, and synthetic biology sit at the intersection of AI, data, and medicine — areas ARK historically treats as multi-decade platforms, not cyclical trades.

The timing suggests Wood sees asymmetric optionality returning, even if fundamentals remain early.

Second, autonomy remains a long-duration bet.

In autonomous mobility, $ARKQ added close to one million shares of $WRD, a robotaxi developer.

$ARKX also added exposure to $ACHR and $AVAV, reinforcing ARK’s view that autonomy isn’t limited to roads — it extends into airspace and defense-adjacent systems.

These are not near-term revenue plays.

They’re infrastructure-of-the-future positions, sized accordingly.

Third, nuclear quietly joins the AI stack.

ARK also added to $OKLO, a U.S. micro-reactor company targeting next-generation nuclear power.

This fits a consistent internal logic:

AI scales on compute.

Compute scales on power.

Power reliability becomes strategic.

It’s a reminder that ARK’s AI thesis increasingly includes energy as a gating variable, not an afterthought.

On the other side of the ledger, the selling is just as telling.

ARK cut roughly 60,700 shares of $TSLA — about $30M — across $ARKK, $ARKW, and $ARKQ.

This isn’t an exit. It’s exposure management.

At the same time, $ARKW trimmed positions in $NET and $PLTR, and reduced stakes in $ROKU and $SHOP.

Smaller reductions included $IBTA and $IONS.

The pattern is consistent:

• Trim positions that already carry large embedded gains

• Reallocate toward earlier-stage, higher-convexity bets

• Maintain exposure to long-term themes without concentration risk

Cathie Wood isn’t turning bearish on innovation.

She’s redistributing capital along the timeline of disruption.

The real question isn’t whether you agree with each name.

It’s whether you agree with the framework:

As technologies mature, do you rotate toward the next S-curve —

or double down on the one already recognized by the market?

📮 Tracking capital rotation across frontier tech, AI-adjacent biology, autonomy, and energy — focusing on where conviction quietly shifts before consensus does.

#CathieWood #ARKInvest #GeneEditing #CRISPR #AutonomousVehicles #AI #Biotech #EnergyTransition